Week In Review: Beijing's Jacobio Completes $174 Million Hong Kong IPO
December 26, 2020 at 13:01 PM EST
Jacobio of Beijing raised $174 million in a Hong Kong IPO to develop its portfolio of 12 novel drugs. Transcenta Holding completed a $105 million funding round to support its global antibody drug development operations.
